FDA Drug Application (202912) for ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE by LUPIN LTD

Back to FDA Applications sponsored by LUPIN LTD

Application Number202912
Product Number001
FormTABLET;ORAL
DosageEQ 300MG BASE;150MG;300MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE
Active IngredientABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE



Back to FDA Applications sponsored by LUPIN LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.